Talazoparib,Enzalutamide,Olaparib,abiraterone,Niraparib,Prednisone
Pfizer,Astellas,Merck,AstraZeneca,Janssen
['prostate', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)']
dr. elena castro provides an excellent overview of #parp inhibitor data in #prostatecancer #gu23 providing the necessary context and caution (incluing using #pfs as a surrogate for survival) 
Clinical researcher focused on #ProstateCancer, early recurrence (#BCR)  & #immunotherapy. Views are my own & do not represent the National Cancer Institute